Related Experiment Video
Updated: Jan 3, 2026
09:21
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
7.5K
MiRNAs as Players in Rhabdomyosarcoma Development
Patrizia Gasparini1, Andrea Ferrari2, Michela Casanova2
1Tumor Genomics Unit, Department of Research; Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
International Journal of Molecular Sciences
|November 23, 2019
Summary
MicroRNAs (miRNAs) are key regulators in rhabdomyosarcoma (RMS) development. Understanding their role as biomarkers and functional drivers may reveal new therapeutic targets for pediatric RMS.
Area of Science:
- Pediatric Oncology
- Molecular Biology
- Biochemistry
Background:
- Rhabdomyosarcoma (RMS) is a rare, aggressive childhood soft tissue sarcoma originating from immature muscle precursor cells.
- Current multimodal therapies improve outcomes, but prognosis varies, necessitating novel therapeutic strategies.
- Understanding RMS molecular mechanisms is crucial for identifying new treatment targets.
Purpose of the Study:
- To review the role of microRNAs (miRNAs) in rhabdomyosarcoma (RMS) pathogenesis.
- To explore miRNAs as potential biomarkers for RMS diagnosis and prognosis.
- To identify miRNAs as functional drivers in RMS development for therapeutic targeting.
Main Methods:
- Literature review focusing on microRNA research in rhabdomyosarcoma.
- Analysis of studies investigating miRNA expression and function in RMS.
- Synthesis of current knowledge on miRNA regulatory roles in skeletal muscle development and RMS.
Main Results:
- MicroRNAs (miRNAs) are established regulators of skeletal muscle cell differentiation.
- Aberrant miRNA expression is implicated in the initiation and progression of rhabdomyosarcoma (RMS).
- Specific miRNAs may serve as diagnostic or prognostic biomarkers in pediatric RMS.
Conclusions:
- MicroRNAs (miRNAs) play significant roles in rhabdomyosarcoma (RMS) development and progression.
- Targeting specific miRNAs could offer novel therapeutic strategies for pediatric RMS.
- Further research into miRNA functions will enhance understanding and clinical management of RMS.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
01:22MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
01:22MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
02:38The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K